Page last updated: 2024-12-08

saccharopine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

L-saccharopine : The N(6)-(1,3-dicarboxypropan-1-yl) derivative of L-lysine. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID160556
CHEBI ID16927
SCHEMBL ID187831
MeSH IDM0262880

Synonyms (41)

Synonym
n-[(5s)-5-amino-5-carboxypentyl]-l-glutamic acid
CHEBI:16927
n-(5-amino-5-carboxypentyl)glutamic acid
997-68-2
n6-(l-1,3-dicarboxypropyl)-l-lysine
C00449
l-saccharopine
epsilon-n-(l-glutar-2-yl)-l-lysine
SACCHAROPINE ,
n-[(s)-5-amino-5-carboxypentyl]-l-glutamic acid
DB04207
BE230516-20C4-4441-BF27-4117776E281D
unii-wbq73o8w32
l-glutamic acid, n-(5-amino-5-carboxypentyl)-, (s)-
accharopin
wbq73o8w32 ,
SCHEMBL187831
n-((5s)-5-amino-5-carboxypentyl)-l-glutamic acid
saccharopine, l-
saccharopin
.epsilon.-n-(l-glutar-2-yl)-l-lysine
l-glutamic acid, n-((5s)-5-amino-5-carboxypentyl)-
l-saccharopine [mi]
l-glutamic acid, n-[(5s)-5-amino-5-carboxypentyl]-
(2s)-2-{[(5s)-5-amino-5-carboxypentyl]amino}pentanedioic acid
n-(5-amino-5-carboxypentyl)-l-glutamic acid
(s)-n-(5-amino-5-carboxypentyl)-l-glutamic acid
n(6)-(l-1,3-dicarboxypropyl)-l-lysine
n-(5-amino-5-carboxypentyl)-glutamic acid
l-saccharopin
l-n-(5-amino-5-carboxypentyl)-glutamic acid
AKOS030623049
(s)-2-((s)-5-amino-5-carboxypentylamino)pentanedioic acid
Q3132238
((s)-5-amino-5-carboxypentyl)-l-glutamic acid
(2s)-2-[[(5s)-5-amino-5-carboxypentyl]amino]pentanedioic acid
2-[(5-amino-5-carboxy-pentyl)amino]pentanedioic acid
A937066
DTXSID80862507
HY-W040307
CS-W021047

Research Excerpts

Overview

Saccharopine reductase is a homodimer. Each subunit consists of three domains, which are not consecutive in amino acid sequence.

ExcerptReferenceRelevance
"Saccharopine reductase is a homodimer, and each subunit consists of three domains, which are not consecutive in amino acid sequence."( Crystal structure of saccharopine reductase from Magnaporthe grisea, an enzyme of the alpha-aminoadipate pathway of lysine biosynthesis.
Johansson, E; Lindqvist, Y; Schneider, G; Steffens, JJ, 2000
)
1.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
Saccharomyces cerevisiae metaboliteAny fungal metabolite produced during a metabolic reaction in Baker's yeast (Saccharomyces cerevisiae).
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
L-lysine derivativeA proteinogenic amino acid derivative resulting from reaction of L-lysine at the amino group or the carboxy group, or from the replacement of any hydrogen of L-lysine by a heteroatom.
amino acid opineAny opine whose structure is based on the condensation of an amino acid with a carbohydrate or a keto-acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (17)

PathwayProteinsCompounds
Metabolism14961108
Amino acid and derivative metabolism250260
Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism4485
Lysine catabolism1031
Lysine Degradation1324
Saccharopinuria/Hyperlysinemia II1324
Hyperlysinemia I, Familial1324
Hyperlysinemia II or Saccharopinuria1324
Pyridoxine Dependency with Seizures1324
2-Aminoadipic 2-Oxoadipic Aciduria1324
Lysine Metabolism722
Lysine degradation ( Lysine degradation )2029
NAD+ + L-Saccharopine + H2O = NADH + L-2-Amino-adipate 6-semialdehyde + L-Glutamic acid ( Lysine degradation )16
Metabolic Epileptic Disorders2589
Biochemical pathways: part I0466
Vitamin B6-dependent and responsive disorders219
Lysine degradation II318

Research

Studies (43)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (18.60)18.7374
1990's8 (18.60)18.2507
2000's6 (13.95)29.6817
2010's15 (34.88)24.3611
2020's6 (13.95)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.97

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.97 (24.57)
Research Supply Index3.81 (2.92)
Research Growth Index5.17 (4.65)
Search Engine Demand Index43.64 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.97)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (9.09%)6.00%
Case Studies0 (0.00%)4.05%
Observational1 (2.27%)0.25%
Other39 (88.64%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]